Galcanezumab is as effective and well tolerated in older patients with migraine as in younger patients, with a higher proportion of older patients achieving an excellent response to the treatment.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/older-age-associated-improved-response-galcanezumab-migraine-2025a1000sdt?src=rss
Author :
Publish date : 2025-10-22 12:00:00
Copyright for syndicated content belongs to the linked Source.
